Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Who and when to vaccinate against influenza.

Buchy P, Badur S.

Int J Infect Dis. 2020 Feb 25. pii: S1201-9712(20)30098-9. doi: 10.1016/j.ijid.2020.02.040. [Epub ahead of print] Review.

2.

Vaccinating pregnant women against influenza needs to be a priority for all countries: An expert commentary.

Buchy P, Badur S, Kassianos G, Preiss S, Tam JS.

Int J Infect Dis. 2020 Mar;92:1-12. doi: 10.1016/j.ijid.2019.12.019. Epub 2019 Dec 19. Review.

3.

Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?

Akyüz F, Çavuş B, Pınarbaşı B, Bozacı M, Baran B, Akyuz U, Uyanıkoglu A, Demir K, Beşışık F, Özdil S, Boztaş G, Mungan Z, Badur S, Yenen S, Kaymakoglu S.

Ann Hepatol. 2019 Jul - Aug;18(4):585-589. doi: 10.1016/j.aohep.2019.01.007. Epub 2019 May 4.

4.

Systematic review of the rotavirus infection burden in the WHO-EMRO region.

Badur S, Öztürk S, Pereira P, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O, Hanif K, Saha D.

Hum Vaccin Immunother. 2019;15(11):2754-2768. doi: 10.1080/21645515.2019.1603984. Epub 2019 May 17.

5.

Application of an immunoglobulin Y-alkaline phosphatase bioconjugate as a diagnostic tool for influenza A virus.

Ozkan B, Budama-Kilinc Y, Cakir-Koc R, Mese S, Badur S.

Bioengineered. 2019 Dec;10(1):33-42. doi: 10.1080/21655979.2019.1586054.

6.

Production and characterization of a conserved M2e peptide-based specific IgY antibody: evaluation of the diagnostic potential via conjugation with latex nanoparticles.

Budama-Kilinc Y, Cakir-Koc R, Ozdemir B, Kaya Z, Badur S.

Prep Biochem Biotechnol. 2018;48(10):930-939. doi: 10.1080/10826068.2018.1525564. Epub 2018 Nov 2.

PMID:
30388960
7.

[Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life].

Devecioğlu E, Gökçay G, Boran P, Eren T, Yılmaz G, Badur S.

Mikrobiyol Bul. 2018 Jul;52(3):324-327. doi: 10.5578/mb.67169. Turkish.

8.

Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.

Caini S, Spreeuwenberg P, Kusznierz GF, Rudi JM, Owen R, Pennington K, Wangchuk S, Gyeltshen S, Ferreira de Almeida WA, Pessanha Henriques CM, Njouom R, Vernet MA, Fasce RA, Andrade W, Yu H, Feng L, Yang J, Peng Z, Lara J, Bruno A, de Mora D, de Lozano C, Zambon M, Pebody R, Castillo L, Clara AW, Matute ML, Kosasih H, Nurhayati, Puzelli S, Rizzo C, Kadjo HA, Daouda C, Kiyanbekova L, Ospanova A, Mott JA, Emukule GO, Heraud JM, Razanajatovo NH, Barakat A, El Falaki F, Huang SQ, Lopez L, Balmaseda A, Moreno B, Rodrigues AP, Guiomar R, Ang LW, Lee VJM, Venter M, Cohen C, Badur S, Ciblak MA, Mironenko A, Holubka O, Bresee J, Brammer L, Hoang PVM, Le MTQ, Fleming D, Séblain CE, Schellevis F, Paget J; Global Influenza B Study group.

BMC Infect Dis. 2018 Jun 8;18(1):269. doi: 10.1186/s12879-018-3181-y.

9.

Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B.

Ciftci S, Keskin F, Abaci N, Akyuz F, Cakiris A, Badur S, Kaymakoglu S, Ustek D.

Clin Lab. 2018 Mar 1;64(3):303-310. doi: 10.7754/Clin.Lab.2017.170616.

PMID:
29739114
10.

Influenza surveillance in Western Turkey in the era of quadrivalent vaccines: A 2003-2016 retrospective analysis.

Meşe S, Uyanik A, Özakay A, Öztürk S, Badur S.

Hum Vaccin Immunother. 2018;14(8):1899-1908. doi: 10.1080/21645515.2018.1452577. Epub 2018 Apr 25.

11.

Active Surveillance of Influenza A and Other Respiratory Viruses in Children with Influenza-like-illness in Two Seasons.

Girit S, Karaaslan A, Gençer S, Yılmaz E, Ayhan Y, Vayvada ER, Akçay Ciblak M, Badur S, Akın Y.

J Infect Dev Ctries. 2018 Jan 10;11(12):944-949. doi: 10.3855/jidc.8867.

12.

Respiratory viral infection`s frequency and clinical outcome in symptomatic children with cancer: A single center experience from a middle-income country.

Büyükkapu-Bay S, Kebudi R, Görgün Ö, Meşe S, Zülfikar B, Badur S.

Turk J Pediatr. 2018;60(6):653-659. doi: 10.24953/turkjped.2018.06.005.

13.

Respiratory Viral Infections and Coinfections Caused by Human Metapneumovirus in Children With Cancer.

Büyükkapu Bay S, Kebudi R, Badur S.

Pediatr Infect Dis J. 2017 Sep;36(9):917. doi: 10.1097/INF.0000000000001624. No abstract available.

PMID:
28806356
14.

[Mortality related factors in patients requiring hospitalization for influenza like illness].

Özışık L, Durusu Tanrıöver M, Çıblak Akçay M, Yuntçu K, Ünal S, Badur S, Çakır B.

Mikrobiyol Bul. 2017 Jan;51(1):20-31. Turkish.

15.

Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.

Ormeci A, Aydın Y, Sumnu A, Baran B, Soyer OM, Pınarbasi B, Gokturk S, Gulluoglu M, Onel D, Badur S, Akyuz F, Karaca C, Demir K, Besisik F, Kaymakoglu S.

Int J Infect Dis. 2016 Nov;52:68-73. doi: 10.1016/j.ijid.2016.09.007. Epub 2016 Sep 9.

16.

Analytical performance of the BD veritor™ system for rapid detection of influenza virus A and B in a primary healthcare setting.

Mese S, Akan H, Badur S, Uyanik A; Istanbul Rapid Test Study Group.

BMC Infect Dis. 2016 Sep 9;16:481. doi: 10.1186/s12879-016-1811-9.

17.

Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the Global Influenza Hospital Surveillance Network.

Puig-Barberà J, Burtseva E, Yu H, Cowling BJ, Badur S, Kyncl J, Sominina A; GIHSN.

BMC Public Health. 2016 Aug 22;16 Suppl 1:757. doi: 10.1186/s12889-016-3378-1.

18.

[Evaluation of sentinel influenza surveillance of the last two seasons: 2013-2014 and 2014-2015].

Meşe S, Asar S, Tulunoğlu M, Uyanık A, Yenen OŞ, Ağaçfidan A, Badur S.

Mikrobiyol Bul. 2016 Jul;50(3):418-27. Turkish.

19.

Influenza in the pediatric population in Istanbul: a one center experience 2009-2014.

Törün SH, Karakılıç E, Aktürk H, Sütçü M, Uysalol M, Cıplak M, Badur S, Salman N, Somer A.

Epidemiol Mikrobiol Imunol. 2016 Mar;65(1):46-50.

PMID:
27246644
20.

Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network.

Puig-Barberà J, Natividad-Sancho A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, Badur S, Yu H, Cowling BJ, El Guerche-Séblain C, Mira-Iglesias A, Kisteneva L, Stolyarov K, Yurtcu K, Feng L, López-Labrador X, Burtseva E; Global Influenza Hospital Surveillance Study Group (GIHSN).

PLoS One. 2016 May 19;11(5):e0154970. doi: 10.1371/journal.pone.0154970. eCollection 2016.

21.

Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?

Caini S, Andrade W, Badur S, Balmaseda A, Barakat A, Bella A, Bimohuen A, Brammer L, Bresee J, Bruno A, Castillo L, Ciblak MA, Clara AW, Cohen C, Daouda C, de Lozano C, De Mora D, Dorji K, Emukule GO, Fasce RA, Feng L, Ferreira de Almeida WA, Guiomar R, Heraud JM, Holubka O, Huang QS, Kadjo HA, Kiyanbekova L, Kosasih H, Kusznierz G, Lee V, Lara J, Li M, Lopez L, Mai HP, Pessanha HC, Matute ML, Mironenko A, Moreno B, Mott JA, Njouom R, Nurhayati, Ospanova A, Owen R, Pebody R, Pennington K, Puzelli S, Quynh Le MT, Razanajatovo NH, Rodrigues A, Rudi JM, Venter M, Vernet MA, Wei AL, Wangchuk S, Yang J, Yu H, Zambon M, Schellevis F, Paget J; Global Influenza B Study.

PLoS One. 2016 May 2;11(5):e0155089. doi: 10.1371/journal.pone.0155089. eCollection 2016.

22.

Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?

Caini S, Andrade W, Badur S, Balmaseda A, Barakat A, Bella A, Bimohuen A, Brammer L, Bresee J, Bruno A, Castillo L, Ciblak MA, Clara AW, Cohen C, Cutter J, Daouda C, de Lozano C, De Mora D, Dorji K, Emukule GO, Fasce RA, Feng L, Ferreira de Almeida WA, Guiomar R, Heraud JM, Holubka O, Huang QS, Kadjo HA, Kiyanbekova L, Kosasih H, Kusznierz G, Lara J, Li M, Lopez L, Mai Hoang PV, Pessanha Henriques CM, Matute ML, Mironenko A, Moreno B, Mott JA, Njouom R, Nurhayati, Ospanova A, Owen R, Pebody R, Pennington K, Puzelli S, Quynh Le MT, Razanajatovo NH, Rodrigues A, Rudi JM, Tzer Pin Lin R, Venter M, Vernet MA, Wangchuk S, Yang J, Yu H, Zambon M, Schellevis F, Paget J; Global Influenza B Study.

PLoS One. 2016 Mar 31;11(3):e0152310. doi: 10.1371/journal.pone.0152310. eCollection 2016. Erratum in: PLoS One. 2016;11(5):e0155089.

23.

Factors affecting uptake of influenza vaccination among family physicians.

Akan H, Yavuz E, Yayla ME, Külbay H, Kaspar EÇ, Zahmacıoğlu O, Badur S.

Vaccine. 2016 Mar 29;34(14):1712-8. doi: 10.1016/j.vaccine.2016.01.057. Epub 2016 Feb 18.

PMID:
26899374
24.

Evaluation of epidemiological and clinical features of influenza and other respiratory viruses.

Aktürk H, Sütçü M, Badur S, Törün SH, Çıtak A, Erol OB, Somer A, Salman N.

Turk Pediatri Ars. 2015 Dec 1;50(4):217-25. doi: 10.5152/TurkPediatriArs.2015.2827. eCollection 2015 Dec.

25.

Is obesity associated with healing after non-surgical periodontal therapy? A local vs. systemic evaluation.

Duzagac E, Cifcibasi E, Erdem MG, Karabey V, Kasali K, Badur S, Cintan S.

J Periodontal Res. 2016 Oct;51(5):604-12. doi: 10.1111/jre.12340. Epub 2015 Dec 15.

PMID:
26667347
26.

Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012.

Cohen JM, Silva ML, Caini S, Ciblak M, Mosnier A, Daviaud I, Matias G, Badur S, Valette M, Enouf V, Paget J, Fleming DM; IBGP study team.

PLoS One. 2015 Oct 1;10(10):e0139431. doi: 10.1371/journal.pone.0139431. eCollection 2015.

27.

The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza.

Puig-Barberà J, Tormos A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, Badur S, Yu H, Cowling BJ, Burtseva E; GIHSN Group.

Influenza Other Respir Viruses. 2015 Nov;9(6):277-286. doi: 10.1111/irv.12335.

28.

Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis.

Cifcibasi E, Koyuncuoglu C, Ciblak M, Badur S, Kasali K, Firatli E, Cintan S.

Inflammation. 2015 Oct;38(5):1959-68. doi: 10.1007/s10753-015-0176-3.

PMID:
25939876
29.

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Akyuz F, Karaca C, Demir K, Besisik F, Onel D, Gulluoglu M, Badur S, Kaymakoglu S.

Liver Int. 2015 Oct;35(10):2265-74. doi: 10.1111/liv.12831. Epub 2015 Apr 17.

PMID:
25800974
30.

The role of activated cytotoxic T cells in etiopathogenesis of periodontal disease: does it harm or does it heal?

Cifcibasi E, Ciblak M, Kiran B, Badur S, Firatli E, Issever H, Cintan S.

Sci Rep. 2015 Mar 19;5:9262. doi: 10.1038/srep09262.

31.
32.

Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.

Aydinoglu-Candan Ö, Araz-Erşan B, Gul A, Badur S, Tugal-Tutkun I.

Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):457-65. doi: 10.1007/s00417-014-2856-3. Epub 2014 Dec 12.

PMID:
25500983
33.

Acute hepatitis B due to immune-escape mutations in a naturally immune patient.

Kaymakoglu S, Baran B, Onel D, Badur S, Atamer T, Akyuz F.

Acta Gastroenterol Belg. 2014 Jun;77(2):262-5.

PMID:
25090827
34.

Incentives and barriers regarding immunization against influenza and hepatitis of health care workers.

FitzSimons D, Hendrickx G, Lernout T, Badur S, Vorsters A, Van Damme P.

Vaccine. 2014 Aug 27;32(38):4849-54. doi: 10.1016/j.vaccine.2014.06.072. Epub 2014 Jun 23.

PMID:
24968151
35.

Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults.

Ergönül Ö, Alan S, Ak Ö, Sargın F, Kantürk A, Gündüz A, Engin D, Öncül O, Balkan II, Ceylan B, Benzonana N, Yazıcı S, Şimşek F, Uzun N, Inan A, Gulhan E, Ciblak M, Midilli K, Ozyurt M, Badur S, Gencer S, Nazlıcan O, Özer S, Özgüneş N, Yıldırmak T, Aslan T, Göktaş P, Saltoğlu N, Fincancı M, Dokucu AI, Eraksoy H; Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK); Pandemic Influenza Study Group.

BMC Infect Dis. 2014 Jun 10;14:317. doi: 10.1186/1471-2334-14-317.

36.

Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method.

Ciftci S, Keskin F, Cakiris A, Akyuz F, Pinarbasi B, Abaci N, Dincer E, Badur S, Kaymakoglu S, Ustek D.

Diagn Microbiol Infect Dis. 2014 May;79(1):25-30. doi: 10.1016/j.diagmicrobio.2014.01.005. Epub 2014 Jan 14.

PMID:
24630522
37.

BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.

Cakal B, Uygunoglu U, Saip S, Altintas A, Siva A, Badur S.

J Immunoassay Immunochem. 2014;35(4):398-411. doi: 10.1080/15321819.2014.885447.

PMID:
24547871
38.

Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B.

Keskin O, Ormeci AC, Baran B, Kabaçam G, Tüzün A, Karatayli E, Akyüz F, Karatayli S, Bozdayi AM, Onel D, Badur S, Idilman R, Kaymakoglu S, Yurdaydin C.

Antivir Ther. 2014;19(6):543-50. doi: 10.3851/IMP2732. Epub 2014 Feb 12.

PMID:
24517926
39.

Viral etiology of influenza-like illnesses during the influenza season between December 2011 and April 2012.

Karadag-Oncel E, Ciblak MA, Ozsurekci Y, Badur S, Ceyhan M.

J Med Virol. 2014 May;86(5):865-71. doi: 10.1002/jmv.23747. Epub 2013 Sep 16.

PMID:
24105787
40.

Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.

Mese S, Arikan M, Cakiris A, Abaci N, Gumus E, Kursun O, Onel D, Ustek D, Kaymakoglu S, Badur S, Yenen OS, Bozkaya E.

J Gen Virol. 2013 Dec;94(Pt 12):2729-2738. doi: 10.1099/vir.0.053041-0. Epub 2013 Sep 17.

PMID:
24045109
41.

Clinical features of hepatitis B virus genotypes in Turkish patients.

Ciftci S, Keskin F, Badur S.

J Pak Med Assoc. 2012 Aug;62(8):759-63.

42.

Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C.

Uyanikoglu A, Akyuz F, Baran B, Simsek BP, Ermis F, Demir K, Gulluoglu M, Badur S, Kaymakoglu S.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):485-90. doi: 10.1016/j.clinre.2013.03.002. Epub 2013 May 9.

PMID:
23665172
43.

Molecular and serological investigations of the Influenza A(H1N1) 2009 pandemic virus in Turkey.

Akcay Ciblak M, Hasoksuz M, Kanturvardar M, Asar S, Badur S.

Med Microbiol Immunol. 2013 Aug;202(4):277-84. doi: 10.1007/s00430-013-0291-4. Epub 2013 Mar 13.

PMID:
23483248
44.

Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Bozbey HU, Akyuz F, Karaca C, Demir K, Besisik F, Onel D, Gulluoglu M, Badur S, Kaymakoglu S.

Antimicrob Agents Chemother. 2013 Apr;57(4):1790-6. doi: 10.1128/AAC.02600-12. Epub 2013 Feb 4.

45.

[Influenza surveillance in nine consecutive seasons, 2003-2012: results from National Influenza Reference Laboratory, Istanbul Faculty Of Medicine, Turkey].

Akçay Ciblak M, Kanturvardar Tütenyurd M, Asar S, Tulunoğlu M, Fındıkçı N, Badur S.

Mikrobiyol Bul. 2012 Oct;46(4):575-93. Turkish.

PMID:
23188572
46.

Frequency of common viruses in etiology of acute respiratory tract infections.

Beka H, Kilic A, Unuvar E, Onel M, Oguz F, Sidal M, Aslan S, Bozkaya E, Badur S, Agacfidan A.

Indian J Pediatr. 2013 Feb;80(2):91-6. doi: 10.1007/s12098-012-0880-z. Epub 2012 Sep 29.

48.

[Evaluation of serological status of children following hepatitis B vaccination during infancy].

Süleyman A, Gökçay G, Badur S, Aykın S, Kılıç G, Tamay Z, Unüvar E, Güler N.

Mikrobiyol Bul. 2012 Jan;46(1):47-56. Turkish.

PMID:
22399171
49.

Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir®) on 2010-2011 seasonal influenza viruses: an open phase IV study.

Ceyhan M, Karadag Oncel E, Badur S, Ciblak MA, Alhan E, Celik US, Kurugol Z, Saz EU, Ozsurekci Y, Celik M, Parlakay AO.

Int J Infect Dis. 2012 Apr;16(4):e273-8. doi: 10.1016/j.ijid.2011.12.008. Epub 2012 Feb 5.

50.

Viral etiology in hospitalized children with acute lower respiratory tract infection.

Hatipoğlu N, Somer A, Badur S, Unüvar E, Akçay-Ciblak M, Yekeler E, Salman N, Keser M, Hatipoğlu H, Siraneci R.

Turk J Pediatr. 2011 Sep-Oct;53(5):508-16.

PMID:
22272450

Supplemental Content

Support Center